Kenya - English - Pharmacy and Poisons Board

macleods pharmaceuticals limited atlanta arcade church road andheri ( east) mumbai - rifampicin 60 mg isoniazid 60 mg dispersible… - dispersible tablet - rifampicin bp 60 mg isoniazid bp 60 mg - antimycobacterials: combinations of drugs for

Kenya - English - Pharmacy and Poisons Board

macleods pharmaceuticals limited atlanta arcade church road near leela hotel - rifampicin 60 mg isoniazid 30 mg pyrazinamide150… - dispersible tablet - rifampicin bp 60 mg isoniazid bp 30 mg … - antimycobacterials: combinations of drugs for

Kenya - English - Pharmacy and Poisons Board

macleods pharmaceuticals limited 304, atlanta arcade, marol church road, andheri - rifampicin isoniazid pyrazinamide - dispersible tablet - rifampicin bp 75 mg isoniazid bp 50 mg… - antimycobacterials: combinations of drugs for

Kenya - English - Pharmacy and Poisons Board

macleods pharmaceuticals limited 304, atlanta arcade, marol church road, andheri - rifampicin isoniazid - dispersible tablet - rifampicin bp 75 mg isoniazid bp 50 mg - antimycobacterials: combinations of drugs for

Singapore - English - HSA (Health Sciences Authority)

goldplus universal pte ltd - rifampicin - capsule - rifampicin 150mg

Ireland - English - HPRA (Health Products Regulatory Authority)

sandoz gmbh - rifampicin - capsule - 300mg milligram

Singapore - English - HSA (Health Sciences Authority)

goldplus universal pte ltd - rifampicin - capsule - 300 mg - rifampicin 300 mg

Malta - English - Medicines Authority

central procurement & supplies unit - rifampicin - capsule - rifampicin 300 mg - antimycobacterials

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - rifampicin, quantity: 600 mg - injection, powder for - excipient ingredients: sodium hydroxide; sodium formaldehyde sulfoxylate - tuberculosis. in the initial treatment and in re-treatment of patients with tuberculosis, rifadin must be used in conjunction with at least one other antituberculosis drug. leprosy. in the management of lepromatous leprosy and dimorphous leprosy to effect speedy conversion of the infectious state to the noninfectious state, which may be expected to occur in 3 to 4 months of treatment. as an alterantive drug in lepromatous, dimorphous, indeterminate and tuberculoid leprosy resistant to sulfones and other antileprosy drugs. as an alternative drug in all those patients having true drug allergy to the more commonly used antileprosy drugs. meningococcal disease. prophylaxis of meningococcal disease in close contacts of known cases and in carriers. (rifadin is not indicated for the treatment of meningococcal infections). haemophilus influenzae. prophylaxis of household contacts of patients with h. influenzae type b.

Malta - English - Medicines Authority

medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - rifampicin - hard capsule - rifampicin 300 mg - antimycobacterials